Fluorometric Determination of Hydroflumethiazide in Human Plasma and Urine After Its Oral Administration
Overview
Authors
Affiliations
A spectrofluorometric method for determination of hydroflumethiazide in human plasma and urine has been developed. The limit of detection was 10 ng/ml plasma and 100 ng/ml urine. The plasma concentration of hydroflumethiazide was determined for 9-11 hours and excretion in urine for 24-37 hrs after oral administration of about 1 mg/kg body weight to 7 subjects. Plasma half life in healthy subjects was 1.9-2.1 h, and 2.7-8.6 h in patients during the period 4-9 hrs after dosing. Cumulative excretion in urine was 67-79% of the dose during 31-37 hrs in 6 subjects; one patient with renal disease was found to excrete only 25.8% of dose during 24 hours. Renal clearance of hydroflumethiazide was higher in the healthy subjects (0.29-0.44 1 h-1 kg-1) than in the patients (0.040-0.15 1 h-1 kg-1). Plasma half life of hydroflumethiazide was not closely correlated with renal clearance of the drug, which suggests that other factors may play a role in determining plasma half life.
A fluorimetric assay for metolazone in urine.
Vose C, Stevens P, Muirhead D, Palmer R, McInnes G Br J Clin Pharmacol. 1980; 9(2):213-5.
PMID: 7356909 PMC: 1429855. DOI: 10.1111/j.1365-2125.1980.tb05836.x.
Clinical pharmacokinetics of diuretics.
BEERMANN B Clin Pharmacokinet. 1980; 5(3):221-45.
PMID: 6993083 DOI: 10.2165/00003088-198005030-00003.
Pharmacokinetics of a single oral dose of hydroflumethiazide in health and in cardiac failure.-.
Brors O, Jacobsen S, Arnesen E Eur J Clin Pharmacol. 1978; 14(1):29-37.
PMID: 729604 DOI: 10.1007/BF00560255.
Distribution of elimination of hydroflumethiazide in man.
Brors O, Jacobsen S Eur J Clin Pharmacol. 1979; 16(2):125-31.
PMID: 499309 DOI: 10.1007/BF00563119.
Excretion of hydroflumethiazide in bile and urine of man.
Brors O, Haffner J, Jacobsen S Eur J Clin Pharmacol. 1979; 15(4):287-9.
PMID: 477714 DOI: 10.1007/BF00618519.